Trial Details

COMPLETED
Basic Information
Clinical ID c1332
Identifier NCT00036439
Trial Title A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: Infliximab
Participant Information
Sponsor Centocor, Inc.
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2025-02-02
Primary Completion Date -
Completion Date 2025-01-07